Total Payments
$2,029
2024 Payments
$125.05
Companies
24
Transactions
129
Medicare Patients
6,204
Medicare Billing
$258,852
Payment Breakdown by Category
Food & Beverage$2,015 (99.3%)
Education$14.74 (0.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,015 | 128 | 99.3% |
| Education | $14.74 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $493.26 | 31 | $0 (2021) |
| PFIZER INC. | $239.66 | 15 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $228.26 | 15 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $193.90 | 12 | $0 (2024) |
| Novo Nordisk Inc | $146.04 | 9 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $144.84 | 10 | $0 (2024) |
| ABBVIE INC. | $105.48 | 5 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $60.76 | 4 | $0 (2019) |
| Lilly USA, LLC | $51.13 | 3 | $0 (2023) |
| Astellas Pharma US Inc | $47.28 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $125.05 | 7 | Novo Nordisk Inc ($39.13) |
| 2023 | $101.18 | 6 | Boehringer Ingelheim Pharmaceuticals, Inc. ($33.80) |
| 2022 | $118.19 | 7 | ABBVIE INC. ($52.79) |
| 2021 | $275.21 | 19 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($106.80) |
| 2020 | $373.44 | 24 | Janssen Pharmaceuticals, Inc ($115.96) |
| 2019 | $271.61 | 16 | Janssen Pharmaceuticals, Inc ($42.40) |
| 2018 | $287.49 | 19 | Janssen Pharmaceuticals, Inc ($131.76) |
| 2017 | $477.27 | 31 | Janssen Pharmaceuticals, Inc ($173.06) |
All Payment Transactions
129 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/09/2024 | Seqirus USA Inc | Fluad (Biological), Flucelvax | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Vaccines | ||||||
| 07/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $22.21 | General |
| 06/03/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Diabetes | ||||||
| 04/02/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: Diabetes | ||||||
| 03/18/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.23 | General |
| Category: Cardiovascular | ||||||
| 02/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $16.23 | General |
| 02/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Diabetes | ||||||
| 11/07/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: DIABETES | ||||||
| 10/10/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: Diabetes | ||||||
| 09/05/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Diabetes | ||||||
| 08/22/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Diabetes | ||||||
| 04/04/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: DIABETES | ||||||
| 03/21/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/15/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Diabetes | ||||||
| 08/16/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Diabetes | ||||||
| 08/15/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: NEUROSCIENCE | ||||||
| 04/28/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/16/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Gastroenterology | ||||||
| 02/09/2022 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/02/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Gastroenterology | ||||||
| 09/22/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Gastroenterology | ||||||
| 09/21/2021 | Abbott Laboratories | FreeStyle Libre (Device) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Diabetes Care | ||||||
| 08/23/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: UROLOGY | ||||||
| 08/23/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: DIABETES | ||||||
| 08/11/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,251 | 1,902 | $627,070 | $47,152 |
| 2022 | 20 | 1,656 | 2,322 | $1.2M | $79,293 |
| 2021 | 18 | 1,806 | 3,201 | $1.0M | $73,769 |
| 2020 | 18 | 1,491 | 2,694 | $981,587 | $58,637 |
Total Patients
6,204
Total Services
10,119
Medicare Billing
$258,852
Procedure Codes
71
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 79 | 86 | $189,544 | $11,300 | 6.0% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 98 | 104 | $163,072 | $8,978 | 5.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 33 | 33 | $189,189 | $5,720 | 3.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 586 | 994 | $25,148 | $5,716 | 22.7% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 59 | 157 | $6,280 | $4,613 | 73.5% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 61 | 71 | $5,325 | $3,696 | 69.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 62 | 71 | $4,970 | $2,623 | 52.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 26 | $24,466 | $1,513 | 6.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 115 | 168 | $1,436 | $1,337 | 93.1% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 21 | 21 | $15,015 | $928.74 | 6.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 59 | 98 | $1,470 | $332.14 | 22.6% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 11 | 12 | $180.00 | $176.40 | 98.0% |
| 85651 | Red blood cell sedimentation rate, to detect inflammation, non-automated | Office | 2023 | 17 | 23 | $345.00 | $96.14 | 27.9% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 24 | 26 | $390.00 | $80.86 | 20.7% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 12 | 12 | $240.00 | $42.40 | 17.7% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 119 | 123 | $271,092 | $17,286 | 6.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 51 | 51 | $292,383 | $9,180 | 3.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 61 | 110 | $146,630 | $8,411 | 5.7% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 73 | 76 | $119,168 | $7,180 | 6.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 42 | 45 | $116,865 | $6,586 | 5.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 570 | 935 | $21,958 | $5,387 | 24.5% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2022 | 72 | 191 | $7,640 | $5,216 | 68.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 56 | 90 | $84,690 | $4,831 | 5.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 86 | 90 | $6,300 | $3,359 | 53.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 34 | 36 | $56,016 | $2,825 | 5.0% |
About Dr. Jeffrey Johnson, M.D
Dr. Jeffrey Johnson, M.D is a Internal Medicine healthcare provider based in Columbia, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689698318.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Johnson, M.D has received a total of $2,029 in payments from pharmaceutical and medical device companies, with $125.05 received in 2024. These payments were reported across 129 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,015).
As a Medicare-enrolled provider, Johnson has provided services to 6,204 Medicare beneficiaries, totaling 10,119 services with total Medicare billing of $258,852. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Columbia, MS
- Active Since 07/26/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1689698318
Products in Payments
- XARELTO (Drug) $445.06
- XIFAXAN (Drug) $268.37
- ELIQUIS (Drug) $210.78
- JARDIANCE (Drug) $155.46
- LYRICA (Drug) $86.67
- Ozempic (Drug) $62.58
- COLOGUARD DNA CAPTURE REAGENTS (Device) $55.14
- INVOKANA (Drug) $48.20
- TOUJEO (Drug) $45.88
- ENTRESTO (Drug) $44.27
- Rybelsus (Drug) $38.65
- BROVANA (Drug) $37.51
- MOUNJARO (Drug) $35.18
- FARXIGA (Drug) $30.64
- AVYCAZ (Drug) $26.91
- MYRBETRIQ (Drug) $24.66
- Myrbetriq (Drug) $22.62
- QULIPTA (Drug) $20.76
- GVOKE HYPOPEN (Drug) $18.63
- BELSOMRA (Drug) $18.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Columbia
Dr. Mark Corriere, M.d, M.D
Internal Medicine — Payments: $499,000
Internal Medicine $499,000
Dr. David Nyanjom, M.d, M.D
Internal Medicine — Payments: $191,423
Internal Medicine $191,423
Dr. David Amrol, M.d, M.D
Internal Medicine — Payments: $144,633
Internal Medicine $144,633
Jake Krieg, M.d, M.D
Internal Medicine — Payments: $96,198
Internal Medicine $96,198
Donald Delwood, M.d, M.D
Internal Medicine — Payments: $72,250
Internal Medicine $72,250
Loren Morgan, Md, MD
Internal Medicine — Payments: $41,678
Internal Medicine $41,678